CAXTON CORP - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 56 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$82,000
-6.8%
23,875
+0.2%
0.09%
-8.0%
Q2 2019$88,000
-64.7%
23,821
+0.4%
0.10%
-56.7%
Q1 2019$249,000
+13.7%
23,717
+12.8%
0.23%
-13.2%
Q4 2018$219,000
-13.4%
21,034
+0.2%
0.27%
+13.7%
Q3 2018$253,00020,9860.23%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders